Medical Equipment

The Rise Of Advancements In Deep-Cold Sterile Vial Technology For Biopharmaceutical Applications Is Influencing The Depyrogenated Sterile Empty Vials Market

April 10, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

What Level Of Market Value Growth Is Predicted For The Depyrogenated Sterile Empty Vials Market From 2026 To 2030?

The depyrogenated sterile empty vials market size has seen substantial growth recently. It is anticipated to expand from $3.79 billion in 2025 to $4.09 billion in 2026, at a compound annual growth rate (CAGR) of 7.9%. The historical growth can be ascribed to several factors, including rising volumes of injectable drug production, the broadening of sterile pharmaceutical manufacturing, enhanced regulatory examination of injectable safety, the expansion of biologics and vaccines, and the embracing of borosilicate glass packaging.

The depyrogenated sterile empty vials market is projected to experience substantial expansion over the upcoming years. By 2030, this market is anticipated to reach a valuation of $5.55 billion, demonstrating a compound annual growth rate (CAGR) of 7.9%. Factors driving this growth during the projected period include the escalating demand for biologics and biosimilars, a surge in investments towards aseptic fill-finish facilities, the widening scope of contract manufacturing services, heightened attention on contamination control, and the growing uptake of pre-sterilized packaging solutions. Key trends anticipated within the forecast timeframe encompass the increasing integration of high-purity injectable packaging, a heightened need for ready-to-fill vials, an intensified focus on packaging standards that are endotoxin-free, the broadening application of automated depyrogenation processes, and an elevated prioritization of primary packaging that adheres to regulatory requirements.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/sample.aspx?id=8562&type=smp

Which Key Factors Are Driving The Depyrogenated Sterile Empty Vials Market Growth?

A rise in the global occurrence of infectious diseases is anticipated to boost expansion within the depyrogenated sterile empty vials market. These diseases are defined as illnesses resulting from detrimental microorganisms like bacteria, viruses, parasites, and fungi. Such depyrogenated sterile vials find application in holding injectable medicines for managing infectious disease treatments. Furthermore, depyrogenated sterile empty vials serve the purpose of collecting samples for laboratory analysis. As an example, the Health Security Agency, a UK-based government body, reported in February 2024 that tuberculosis (TB) cases in England saw an increase of 10.7% in 2023 relative to 2022. Specifically, the caseload climbed from 4,380 in 2022 to 4,850 in 2023. Consequently, the growing global incidence of infectious diseases will be a key factor propelling the expansion of the depyrogenated sterile empty vials market.

How Is The Depyrogenated Sterile Empty Vials Market Segmented Across Different Segment Categories?

The depyrogenated sterile empty vials market covered in this report is segmented –

1) By Product: 2 ML, 5 ML, 10 ML, 20 ML, >20 ML

2) By Packaging: Glass, Plastic

3) By End User: Clinical Labs, Compounding Labs, Pharmaceutical Companies, Contract Manufacturing Organization, Distributors

Which Trends Are Guiding The Direction Of The Depyrogenated Sterile Empty Vials Market?

Leading companies in the depyrogenated sterile empty vials market are concentrating on developing novel products, such as deep-cold freeze vials, to address the increasing demand for safer, more reliable biopharmaceutical storage and transport. These deep-cold freeze vials represent specialized sterile vessels engineered for the secure containment of biological substances at exceptionally low temperatures (–80°C to –150°C). Their function is to safeguard delicate medications, vaccines, and specimens from deterioration, preserve sterility, and guarantee product integrity throughout extended storage and transportation. An example is SCHOTT Pharma AG & Co. KGaA, a Germany-based specialty glass manufacturing company, which introduced EVERIC freeze vials in January 2024. This innovative vial family is specifically designed for mRNA and gene-therapy products needing deep-cold storage and superior container integrity. The EVERIC freeze vials are Type I borosilicate glass vessels, produced and certified for ultralow temperature applications. They feature reinforced glass geometry and precise process controls to minimize breakage during freeze-thaw cycles. Furthermore, they are compatible with standard lyophilization and cryogenic logistics, provide controlled dimensional accuracy for automated filling and capping lines, and aim to lessen delamination/particulate hazards while enhancing drug stability compared to traditional vials, thus making them ideal for vaccines, gene-therapy vectors, and other temperature-sensitive biologics.

Which Organizations Play A Role In The Depyrogenated Sterile Empty Vials Market Landscape?

Major companies operating in the depyrogenated sterile empty vials market are APG Pharma, Corning Inc., DWK Life Sciences, Nipro PharmaPackaging, Schott AG, Thermo Fisher Scientific, Gerresheimer AG, Stevanato Group, SGD Pharma, Merck KGaA, SiO2 Materials Science, Shandong Pharmaceutical Glass Co. Ltd., West Pharmaceutical Services Inc., Ompi Srl, Pacific Vial Manufacturing Inc., Adelphi Healthcare Packaging Limited, Acme Vial and Glass Company LLC, Amposan S.A., BMT Corporation, Cangzhou Four Stars Glass Co. Ltd., Zhejiang Pharmaceutical-Packaging Co. Ltd.

Get The Full Depyrogenated Sterile Empty Vials Market Report:

https://www.thebusinessresearchcompany.com/report/depyrogenated-sterile-empty-vials-global-market-report

Which Geographic Region Dominates The Depyrogenated Sterile Empty Vials Market?

North America was the largest region in the depyrogenated sterile empty vials market in 2025. The regions covered in the depyrogenated sterile empty vials market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Depyrogenated Sterile Empty Vials Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/customise?id=8562&type=smp

Browse Through More Reports Similar to the Global Depyrogenated Sterile Empty Vials Market 2026, By The Business Research Company

Sterile Medical Packaging Market Report 2026

https://www.thebusinessresearchcompany.com/report/sterile-medical-packaging-global-market-report

Sterile Compounding Pharmacies Market Report 2026

https://www.thebusinessresearchcompany.com/report/sterile-compounding-pharmacies-global-market-report

Generic Oncology Sterile Injectable Market Report 2026

https://www.thebusinessresearchcompany.com/report/generic-oncology-sterile-injectable-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795